Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Regeneron Pharmaceuticals (REGN) Q4 2022 Earnings
REGN
+0.34%
3
Nov
Confirmed
Q1 2022
Q2 2022
Q3 2022
Q4 2022
8.57
12.82
17.07
21.32
Details
Expected EPS
9.56
Actual EPS
11.14
Surprise EPS
1.58
Surprise Percent
+16.53%
Description
Regeneron Pharmaceuticals (REGN) has reported earnings of 11.14 per share for Q4 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login